Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

310 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Pericytes and immune cells contribute to complement activation in tubulointerstitial fibrosis.
Xavier S, Sahu RK, Landes SG, Yu J, Taylor RP, Ayyadevara S, Megyesi J, Stallcup WB, Duffield JS, Reis ES, Lambris JD, Portilla D. Xavier S, et al. Among authors: taylor rp. Am J Physiol Renal Physiol. 2017 Mar 1;312(3):F516-F532. doi: 10.1152/ajprenal.00604.2016. Epub 2017 Jan 4. Am J Physiol Renal Physiol. 2017. PMID: 28052876 Free PMC article.
Complement C1r serine protease contributes to kidney fibrosis.
Xavier S, Sahu RK, Bontha SV, Mass V, Taylor RP, Megyesi J, Thielens NM, Portilla D. Xavier S, et al. Among authors: taylor rp. Am J Physiol Renal Physiol. 2019 Nov 1;317(5):F1293-F1304. doi: 10.1152/ajprenal.00357.2019. Epub 2019 Sep 11. Am J Physiol Renal Physiol. 2019. PMID: 31509012 Free PMC article.
Complement C5a-Induced Changes in Neutrophil Morphology During Inflammation.
Denk S, Taylor RP, Wiegner R, Cook EM, Lindorfer MA, Pfeiffer K, Paschke S, Eiseler T, Weiss M, Barth E, Lambris JD, Kalbitz M, Martin T, Barth H, Messerer DAC, Gebhard F, Huber-Lang MS. Denk S, et al. Among authors: taylor rp. Scand J Immunol. 2017 Sep;86(3):143-155. doi: 10.1111/sji.12580. Scand J Immunol. 2017. PMID: 28671713 Free PMC article.
'Stealth' corporate innovation: an emerging threat for therapeutic drug development.
Mastellos DC, Blom AM, Connolly ES, Daha MR, Geisbrecht BV, Ghebrehiwet B, Gros P, Hajishengallis G, Holers VM, Huber-Lang M, Kinoshita T, Mollnes TE, Montgomery RA, Morgan BP, Nilsson B, Pio R, Ricklin D, Risitano AM, Taylor RP, Mantovani A, Ioannidis JPA, Lambris JD. Mastellos DC, et al. Among authors: taylor rp. Nat Immunol. 2019 Nov;20(11):1409-1413. doi: 10.1038/s41590-019-0503-1. Nat Immunol. 2019. PMID: 31562490 Free PMC article.
Author Correction: 'Stealth' corporate innovation: an emerging threat for therapeutic drug development.
Mastellos DC, Blom AM, Connolly ES, Daha MR, Geisbrecht BV, Ghebrehiwet B, Gros P, Hajishengallis G, Holers VM, Huber-Lang M, Kinoshita T, Mollnes TE, Montgomery RA, Morgan BP, Nilsson B, Pio R, Ricklin D, Risitano AM, Taylor RP, Mantovani A, Ioannidis JPA, Lambris JD. Mastellos DC, et al. Among authors: taylor rp. Nat Immunol. 2019 Nov;20(11):1556. doi: 10.1038/s41590-019-0531-x. Nat Immunol. 2019. PMID: 31605100
Binding of submaximal C1q promotes complement-dependent cytotoxicity (CDC) of B cells opsonized with anti-CD20 mAbs ofatumumab (OFA) or rituximab (RTX): considerably higher levels of CDC are induced by OFA than by RTX.
Pawluczkowycz AW, Beurskens FJ, Beum PV, Lindorfer MA, van de Winkel JG, Parren PW, Taylor RP. Pawluczkowycz AW, et al. Among authors: taylor rp. J Immunol. 2009 Jul 1;183(1):749-58. doi: 10.4049/jimmunol.0900632. Epub 2009 Jun 17. J Immunol. 2009. PMID: 19535640
310 results